Starr Companies has led a $70m round for Chinese medicine provider Gushengtang that also featured insurance firm Ping An.

The diagnostics technology developer, backed by Allscripts, Celgene and Blackberry, has filed for an initial public offering provisionally sized at up to $92m.

Student-led investment fund Social Venture Fund invests in a second seed round for medical software-as-a-service firm Conversa Health.

The startup accelerator has partnered with a host of US universities to source opportunities as it launches with $11.5m in initial funding.

The gene editing company raised $108m in its IPO, floating at the top of its range, while Regeneron and Novartis provided $55m through concurrent private placements.

Michigan University's latest fund brings together medical and engineering students through a $3m gift from the Monroe-Brown Foundation.

Francesca Domenech Wuttke will lead European digital healthcare investments for corporate venturing unit Merck Global Health Innovation Fund.

Viamet, which has raised about $170m from backers including Novartis, Eli Lilly and Astellas, is set to raise up to $91m, after withdrawing its last IPO filing in 2014.